The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Harley-Davidson (HOG) Faces Intensified H Partners Campaign as Proxy Advisors and Dealers Back Withhold Effort

Summary

The H Partners letter (May 9, 2025) urges Harley-Davidson shareholders to withhold votes from CEO Jochen Zeitz, Thomas Linebarger, and Sara Levinson at the May 14 annual meeting. It blames them for overseeing $6B in value destruction, with Harley underperforming the S&P 400 Consumer Discretionary Index by -403% over their tenure. H Partners highlights Zeitz’s $50M compensation despite $2B in shareholder losses and Harley’s 24% decline in U.S. registrations, versus +23% growth for peers. The campaign has won backing from Glass Lewis, Egan-Jones, investors like Purple Chip Capital, dealer groups, and employees, all criticizing the board as complacent and misaligned. H Partners frames this as a chance to end entrenched underperformance and restore Harley’s iconic brand to growth.

Company Name: Harley-Davidson, Inc.
Symbol: HOG
Filing Date: May-12-2025
Filer Name: H Partners Management, LLC

Download Presentation
Harley-H Partners-May-12-2025.pdf
4 MB
download-circle

Source:

https://www.sec.gov/Archives/edgar/data/793952/000092189525001383/ex1todfan14a10304005b_050925.pdf

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28